Brief: Eckert & Ziegler Pentixapharm Receives Bfarm-Clearance For Its Therapeutic To Conduct A Clinical Trial In Lymphoma
June 8 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG EUZG.DE :
* PENTIXAPHARM RECEIVES BFARM-CLEARANCE FOR ITS THERAPEUTIC
TO
CONDUCT A CLINICAL TRIAL IN LYMPHOMA
Source text for Eikon: ID:nEQ2tJ8nva
Further company coverage: EUZG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth